Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
The ChinaBio® Investor Forum–Jinan chose two...
BeiGene, based in Beijing’s Zhongguancun Life...
WuXi PharmaTech, a leading China CRO, has acquired...
On October 10-11, the ChinaBio® Leadership...
Simcere Pharma signed a strategic cooperation agreement...
Roche will hire an additional 1,000 people in China over...
Sino Biological, a Beijing maker of biologic research...
PerkinElmer paid $38 million to buy Shanghai Haoyuan...
Innovent, an innovative Suzhou startup, has partnered...
BioPacific Investors, an US group of angel investors, has...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
